Article Per Year (5 Year)
p-Index From 2020 - 2025
3.109
P-Index
This Author published in this journals
All Journal Jurnal Peduli Masyarakat JOURNAL SCIENTIFIC OF MANDALIKA (JSM) Jurnal Farmasi dan Sains Indonesia (JFSI) Jurnal Penelitian Inovatif Lux Mensana: Journal of Scientific Health Jurnal Farmasi Indonesia Science and Community Pharmacy Journal
Gloria, Fransisca
Unknown Affiliation
Humanities Biochemistry, Genetics & Molecular Biology Chemistry Education Engineering Health Professions Languange, Linguistic, Communication & Media Medicine & Pharmacology Neuroscience Nursing Public Health Social Sciences Other

Published : 19 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search
Journal : Jurnal Farmasi Indonesia

 1 
Hubungan Sosiodemografi dengan Hasil Klinis Pasien Covid-19 di RSUD Bengkulu Lukas, Stefanus; Ramatillah, Diana Laila; Aldi, Yufri; Wahyuni, Fatma Sri; Gloria, Fransisca; Michael, Michael; Wahyudi, Agung Aji; Astari, Lita Tri
JFIOnline | Print ISSN 1412-1107 | e-ISSN 2355-696X Vol. 14 No. 1 (2022): Jurnal Farmasi Indonesia
Publisher : Pengurus Pusat Ikatan Apoteker Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (411.839 KB) | DOI: 10.35617/jfionline.v14i1.59

Abstract

Coronavirus disease 2019 (Covid-19) adalah penyakit menular yang disebabkan oleh SARS-CoV-2 yang memiliki bentuk dan perilaku menyerupai virus SARS. Persentase angka kematian nasional adalah 4,23, yang berada di atas angka kematian rata-rata nasional. Tujuan penelitian untuk mengetahui faktor-faktor apa saja yang berhubungan dengan kematian pasien Covid-19 di RS Pemerintah Bengkulu.Dengan tujuan Mengetahui hubungan sosiodemografi dengan luaran klinis pasien COVID-19 di Bengkulu.dengan metode Penelitian kohort retrospektif dilakukan dalam penelitian ini. Penelitian ini hanya melibatkan pasien terkonfirmasi COVID-19, dengan total sampel 127 pasien yang dirawat di rumah sakit selama April, Mei, dan Juni 2021.Dan mendapatkan hasil Semua pasien yang dirawat di Rumah Sakit Pemerintah Bengkulu antara April dan Juni 2021 menggunakan azitromisin atau levofloxacin + oseltamivir + vitamin sebagai pengobatan. Hasil dari infeksi covid-19 memiliki beberapa faktor korelasi yang signifikan: usia (0,0001), pekerjaan (0,0001) dan penyakit penyerta (0,0001). Kesimpulan Outcome klinis terburuk paling banyak ditemukan pada pasien yang menderita Diabetes dan berusia lebih dari 50 tahun.
Evaluasi Hasil Klinis Pada Tim Medis yang Mendapat Vaksinasi Booster di Rumah Sakit Bengkayang Kalimantan Barat Lukas, Stefanus; Ramatillah, Diana Laila; Aldi, Yufri; Wahyuni, Fatma Sri; Paulina, Ida; Gloria, Fransisca; Michael, Michael
JFIOnline | Print ISSN 1412-1107 | e-ISSN 2355-696X Vol. 14 No. 2 (2022): Jurnal Farmasi Indonesia
Publisher : Pengurus Pusat Ikatan Apoteker Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (531.685 KB) | DOI: 10.35617/jfionline.v14i2.70

Abstract

Abstract: In reducing the risk of transmission to health workers, the Government has given the 3rd Booster Covid-19 Vaccination since August 2021. This study uses the Astra Zeneca Vaccine, Moderna Vaccine and Pfizer Vaccine. The purpose of this study was to evaluate the effectiveness of the 3rd Booster vaccine and the clinical outcomes of post-vaccination health workers at West Kalimantan Hospital. Research method Observational Cross-sectional Prospective by conducting questionnaires and interviewing health workers. Samples were taken by convenience sampling and statistical analysis of chis-square. The research instrument used a questionnaire distributed in the hospital. In the study, it was found that as many as 12.60% (14 out of 118 health workers) were infected with Covid-19. The habit that influenced the effectiveness of the 3rd booster vaccination was sunbathing (p <0.05). The low severity of health workers infected with Covid-19 after the 3rd booster vaccine can be seen from the place of treatment, namely 97% independent isolation, 60% without using antivirals and 77% without using antibiotics. The type of vitamin that is most widely used is vitamin C. Hence with this booster vaccination aims to prevent and reduce the severity of patients who contract Covid-19 after vaccination.
Co-Authors Addini, Belkis Nur Adiwidjaya Kusuma, Gregorius Adrianto, Madyo Aldila, Silvy Anak Agung Pradnya Paramitha Vidiani Anggraini, Silvira Eka Aprilia, Eka Rosita Arfiyani, Aulia Arofa, Izanur Astari, Lita Tri Auleina, Revly Ana Aulia , Ayu Bagus Ananta Tanujiarso, Bagus Busdha , Desti Dahliyanti, Novita Dwi Dewi, Rissa Maharani Fatma Sri Wahyuni Handayani, Dwi Nurul Hidayah, Ravita Nur Indrasari, Ferika Kurnia Enggolan, Cahaya Lukas, Stefanus Lumayung , Censa Maula, Vita Zulfatul Maulana Akbar, Fatwa Michael Michael NUR HARYANTI Ovikariani, Ovikariani Paulina, Ida Puruhita, Ranatri Puspita, Nella Vallen Ika Ramatillah, Diana Laila Rizki , Gilang Rustaman, Heri Safrida Safrida Sa’adah, Anifatus Septiyana, Ria Sri Suwarni Tunik Saptawati, Tunik Uliana, Syahkhirotul Exma Uswati, Uswati Wahyudi, Agung Aji Widya Mariyana, Widya Yufri Aldi Yuliasari, Niken